Quick Answer
NEUROCRINE BIOSCIENCES INC reported Cash And Cash Equivalents At Carrying Value of $713.00 million for the year ending 2025.
- NEUROCRINE BIOSCIENCES INC showed an increase of +206.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from NEUROCRINE BIOSCIENCES INC's annual report (Form 10-K), filed with the SEC on February 11, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), NEUROCRINE BIOSCIENCES INC's Cash And Cash Equivalents At Carrying Value has grown by 941.4%.
- Historical annual values: Fiscal year 2025: $713.00 million | Fiscal year 2024: $233.00 million | Fiscal year 2023: $251.10 million | Fiscal year 2022: $262.90 million | Fiscal year 2021: $340.80 million | Fiscal year 2020: $187.10 million | Fiscal year 2019: $112.30 million | Fiscal year 2018: $141.71 million | Fiscal year 2017: $254.71 million | Fiscal year 2016: $83.27 million | Fiscal year 2015: $74.20 million | Fiscal year 2014: $31.01 million | Fiscal year 2013: $44.79 million | Fiscal year 2012: $63.75 million | Fiscal year 2011: $50.11 million | Fiscal year 2010: $54.05 million | Fiscal year 2009: $37.33 million | Fiscal year 2008: $68.47 million.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: